PolyNovo (ASX:PNV) said its synthetic dermal scaffold, NovoSorb Monolayer Matrix, comprised of 4mm and 6mm thick NovoSorb technology, received Therapeutic Goods Administration clearance, and can now be marketed and sold in Australia, according to a Monday filing with the Australian bourse.